Jpmorgan Chase & CO Relay Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,909,771 shares of RLAY stock, worth $16.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,909,771

Previous 4,978,443 1.38%

Holding current value

$16.4 Million

Previous $20.5 Million 37.29%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$2.62 - $4.92 $179,920 - $337,866	-68,672 Reduced 1.38%	4,909,771 $12.9 Million
Q4 2024 Feb 12, 2025	SELL	$4.12 - $6.8 $2.22 Million - $3.67 Million	-539,073 Reduced 9.77%	4,978,443 $20.5 Million
Q3 2024 Dec 26, 2024	BUY	$6.23 - $9.51 $9.68 Million - $14.8 Million	1,554,115 Added 39.21%	5,517,516 $39.1 Million
Q3 2024 Nov 08, 2024	BUY	$6.23 - $9.51 $9.68 Million - $14.8 Million	1,554,115 Added 39.21%	5,517,516 $39.1 Million
Q2 2024 Dec 26, 2024	SELL	$5.9 - $8.02 $9.17 Million - $12.5 Million	-1,554,115 Reduced 28.17%	3,963,401 $25.8 Million
Q2 2024 Aug 12, 2024	BUY	$5.9 - $8.02 $1.45 Million - $1.97 Million	246,133 Added 6.62%	3,963,401 $25.8 Million
Q1 2024 Dec 26, 2024	SELL	$7.5 - $12.07 $13.5 Million - $21.7 Million	-1,800,248 Reduced 32.63%	3,717,268 $30.9 Million
Q1 2024 May 10, 2024	SELL	$7.5 - $12.07 $17.6 Million - $28.3 Million	-2,348,327 Reduced 38.72%	3,717,268 $30.9 Million
Q4 2023 Dec 26, 2024	BUY	$6.01 - $11.48 $3.29 Million - $6.29 Million	548,079 Added 9.93%	6,065,595 $66.8 Million
Q4 2023 Feb 12, 2024	BUY	$6.01 - $11.48 $5.58 Million - $10.7 Million	929,111 Added 18.09%	6,065,595 $66.8 Million
Q3 2023 Nov 14, 2023	BUY	$8.24 - $12.97 $1.17 Million - $1.84 Million	141,579 Added 2.83%	5,136,484 $43.2 Million
Q2 2023 Aug 11, 2023	BUY	$9.99 - $18.27 $6.93 Million - $12.7 Million	694,079 Added 16.14%	4,994,905 $62.7 Million
Q1 2023 May 18, 2023	BUY	$15.0 - $22.76 $1.73 Million - $2.62 Million	115,187 Added 2.75%	4,300,826 $70.8 Million
Q1 2023 May 11, 2023	SELL	$15.0 - $22.76 $4.26 Million - $6.47 Million	-284,259 Reduced 6.36%	4,185,639 $68.9 Million
Q4 2022 Feb 13, 2023	SELL	$14.16 - $24.02 $7.77 Million - $13.2 Million	-548,589 Reduced 10.93%	4,469,898 $66.8 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $1.38 Million - $2.39 Million	76,225 Added 1.54%	5,018,487 $112 Million
Q2 2022 Aug 11, 2022	BUY	$13.31 - $34.88 $22.2 Million - $58.2 Million	1,667,873 Added 50.94%	4,942,262 $82.8 Million
Q1 2022 May 11, 2022	SELL	$20.26 - $32.36 $1.88 Million - $3.01 Million	-92,923 Reduced 2.76%	3,274,389 $98 Million
Q4 2021 Feb 10, 2022	BUY	$26.0 - $37.03 $50.4 Million - $71.9 Million	1,940,330 Added 135.97%	3,367,312 $103 Million
Q3 2021 Nov 12, 2021	BUY	$29.75 - $37.99 $42.5 Million - $54.2 Million	1,426,982 New	1,426,982 $45 Million

Others Institutions Holding RLAY

# of Institutions

213

Shares Held

172M

Call Options Held

Put Options Held

36.1K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $403M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Relay Therapeutics, Inc. Transaction History